找不到产品?留下需求帮您找
一键询价HRMVPCS 永生化人视网膜周细胞 QCH791
一周
3500¥
L363 人多发性骨髓瘤细胞 QCH792
一周
4000¥
Colo680N 人食管鳞癌细胞 QCH793
一周
4000¥
hTERT ipNF95.6 人纵状神经纤维瘤细胞 QCH794
一周
8500¥
MDA-PCA-2B 人前列腺癌细胞 QCH795
一周
4500¥
CORL23 人肺癌细胞(大细胞肺1癌)QCH796
一周
3500¥
T3M-4 人胰腺腺癌细胞 QCH797
一周
4500¥
CAL12T 人非小细胞肺癌细胞 QCH798
一周
3500¥
KMS-12-PE 人多发性骨髓瘤细胞 QCH799
一周
4000¥
EFO-27 人卵巢腺癌细胞 QCH800
钦诚生物 | 一周
4000¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:YU238259 产品别名:见爱必信官网 英文别名:YU238259 靶点:HDR CAS:1943733-16-1 纯度:98% 外观:见爱必信官网 保存方法:-20℃ 描述: YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays. 溶解性:DMSO :84 mg/mL (182.6 mM) 体外研究: YU238259 is an inhibitor of homology-dependent DNA repair, with no effect on PARP activity. YU238259 shows cytotoxicity in BRCA2-deficient cells, with a low LD50 of 8.5 μM. YU238259 (0-5 μM) causes a potent, dose-dependent decrease in HDR efficiency in U2OS DR-GFP or U2OS EJ5-GFP cells, but with no effect on NHEJ frequency. YU238259 (0-10 μM) exhibits synthetic lethality with loss of frequently mutated tumor suppressors, and shows synergism with radiotherapy (IR) and DNA-damaging chemotherapy that is potentiated by BRCA2 loss. 体内研究:YU238259 (3 mg/kg, i.p.) inhibits the growth of BRCA2-deficient tumor xenografts in nude mice.
产品信息订购:
|